Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients

NCT05226078 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT05226078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 1, 2023
Completion date
November 30, 2026
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related problem/condition, cancer-related syndrome, chronic insomnia